# Progress Note 07 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Eva Perón (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML025-SYN
- Date: 2026-09-21
- Fictional facility: St. Posthumous Health Center
- Fictional author: Lucía Barragán, MD
- Calendar frame: modern shifted

- Visit type: Preventive Visit
- Services: CPT 99395 (periodic preventive medicine, established patient, age 18 to 39) with CPT 99497 (advance care planning) on the same day

## Chief complaint

Periodic adult preventive visit after cancer treatment. **S**

## History of present illness

Ms. Perón is a 32-year-old foundation director who comes for her yearly preventive visit, four and a half months after finishing chemoradiation and brachytherapy for stage IIB squamous cell carcinoma of the cervix. Her PET-CT a month ago showed a complete metabolic response. She is back at work full time. The estradiol patch and nightly progesterone have stopped the hot flashes and night sweats, and she uses the vaginal dilator three times a week. Her energy is nearly normal, and she finished the iron course last month. She meets the oncology social worker monthly. She asks what else she should be doing to stay well. **S**

| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 32 |
| Cancer | Complete metabolic response on PET-CT a month ago; gynecologic oncology review every three months |
| Menopause care | Estradiol patch and progesterone; symptoms controlled |
| Mood | PHQ-2 0 |
| Work | Full time again |

## Health risk assessment

Completed by the patient in Spanish on a tablet in the waiting room and reviewed with her by Dr. Barragán in Spanish. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good, and better each month |
| Psychosocial | Supported by a close friend and colleagues; sees the oncology social worker monthly; worries before each scan |
| Substance use | AUDIT-C 1; no drugs |
| Tobacco | Never smoked |
| Physical activity | Walks 30 minutes most days; started a weekly exercise class |
| Nutrition | Regular meals; dairy daily; weight back to her usual |
| Sleep | Seven hours; night sweats gone |
| Sexual health | Uses the vaginal dilator three times a week and a lubricant; pregnancy is no longer possible after pelvic radiation |
| Safety at home | Feels safe; no one hurts, threatens, or controls her; no firearm in the home |
| Road safety | Wears a seat belt |
| Activities of daily living | Independent |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever, weight loss, or night sweats |
| Eyes | Negative | No vision change |
| Ears, nose, mouth, and throat | Negative | No hearing change or ringing after cisplatin |
| Cardiovascular | Negative | No chest pain or leg swelling |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | Bowels normal; no rectal bleeding |
| Genitourinary | Negative | No vaginal bleeding or discharge; no urinary symptoms |
| Musculoskeletal | Negative | No bone or back pain |
| Integumentary | Negative | Skin in the radiation field healed; no changing moles |
| Neurological | Negative | No numbness or tingling in the hands or feet |
| Endocrine | Negative | No hot flashes on the patch |
| Psychiatric | Negative | Mood good; PHQ-2 0 |

12 systems reviewed. **S**

## Current medications

- Acetaminophen 500 mg oral tablet, one or two tablets by mouth every 6 hours when needed for pelvic pain, no more than 6 tablets a day **S**
- Estradiol 0.1 mg per day transdermal patch, one patch changed twice weekly **S**
- Progesterone 100 mg oral capsule, one capsule by mouth nightly, to protect any remaining endometrium while on estradiol **S**

## Allergies

- No known allergy **S**

## Objective

BP 110/70 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 52.8 kg; BMI 19.4 kg/m². All vital signs are synthetic.

PHQ-2: 0; AUDIT-C: 1. All results are synthetic.

## Change since baseline

- PHQ-2: 1 at baseline, 0 at this visit **S**

## Immunizations given today

- Influenza vaccine, 2026-2027 season **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well; weight 52.8 kg, BMI 19.4; blood pressure 110/70 |
| Neck | No lymph nodes; thyroid normal |
| Lymph nodes | No supraclavicular or inguinal nodes |
| Cardiovascular | Regular rhythm; no murmur |
| Respiratory | Clear to auscultation bilaterally |
| Abdomen | Soft and non-tender; no mass |
| Breasts | No masses |
| Skin | Radiation field healed; no suspicious lesions |
| Psychiatric | Bright and engaged |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Periodic adult preventive visit completed**. Health risk assessment reviewed and the prevention plan updated for a cancer survivor. Cervical screening is replaced by her gynecologic oncology surveillance. HIV and hepatitis C tests at diagnosis were negative. Influenza vaccine given today. The HPV vaccine was discussed: at 32 it is a shared decision, and it would not treat her cancer; she declined. Pelvic radiation has ended the possibility of pregnancy, so no contraception is needed. **S**
   - Influenza vaccine today.
   - Calcium-rich diet and weight-bearing exercise; estrogen therapy protects bone.
   - Next preventive visit in one year.
2. **Squamous cell carcinoma of the cervix, FIGO 2018 stage IIB** (C53.9). No evidence of disease four and a half months after treatment. **S**
   - Gynecologic oncology review every three months for two years.
   - Report vaginal bleeding, pelvic or back pain, leg swelling, or weight loss without waiting.
3. **Ovarian failure after pelvic radiation** (E89.41). Symptoms controlled on estradiol 0.1 mg patch twice weekly with progesterone 100 mg nightly; blood pressure normal; no clot symptoms. **S**
   - Continue until about the usual age of menopause, reviewed yearly.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 110/70 mmHg |
| Depression screening | Completed today | PHQ-2 score 0; PHQ-9 4 a month ago |
| Unhealthy alcohol use screening | Completed today | AUDIT-C score 1 |
| Tobacco use | Completed today | Never smoked |
| Cervical cancer screening | Not indicated | Replaced by gynecologic oncology surveillance after cervical cancer treatment |
| Contraception and pregnancy intention | Not indicated | Pregnancy is no longer possible after pelvic chemoradiation; discussed with her at diagnosis |
| Intimate partner violence screening | Completed today | Negative; she feels safe |
| HIV and hepatitis C screening | Up to date | Both negative at diagnosis |
| Diabetes and cholesterol screening | Not indicated | Age 32 with a BMI of 19.4 and no risk factors |
| Bone health after early menopause | Completed today | Estrogen therapy in place; calcium-rich diet and weight-bearing exercise advised |
| Influenza vaccine | Completed today | Inactivated influenza vaccine given |
| COVID-19 vaccine | Due | Discussed; she will have the updated vaccine next month |
| Tetanus, diphtheria, and pertussis | Up to date | Tdap four years ago |
| HPV vaccine | Declined | Shared decision at age 27 to 45; she declined, understanding that it would not treat her cancer |
| Measles, mumps, rubella, and hepatitis B | Up to date | Childhood series documented |

## Advance care planning

Voluntary advance care planning discussion of about 18 minutes, in Spanish, with her consent. She named a health care agent, recorded in the confidential part of the chart and not named here. She said that she always wants to be told the truth about her illness herself, first and fully, and that if her cancer ever returned and could not be cured she would want care focused on comfort and on being able to keep working as long as possible. She asked that her wishes be written in Spanish as well as English. To be revisited yearly or if her health changes. **S**

## Guideline basis

- NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer (Version 1.2027), National Comprehensive Cancer Network
- Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline (2017), American Society of Clinical Oncology (Journal of Clinical Oncology)
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Medical Condition and Other Indication (2026), Centers for Disease Control and Prevention

## Follow-up

- Gynecologic oncology review next month. Next preventive visit in one year. **S**

